LIN trades against a final fair-value range of $208.99-$355.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $209, high $356, with mid-point at $277.
इस रिपोर्ट का अभी अनुवाद नहीं हुआ है। अनुवाद कतार पकड़ने पर कुछ मिनट में रिफ़्रेश करें।
§1 कार्यकारी सारांश
Composite fair value $277 with high case $356.
Implied downside of 43.9% to fair value.
Moat 9/10 · confidence 87/100 · Cyclical.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$277
Margin of safety
-78.2%
Confidence
87/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$493.16Price
FV $276.69
High $355.92
LIN trades against a final fair-value range of $208.99-$355.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Cycle upside
Secular energy transition optimism and continuous pricing power drive unconstrained multiple expansion.
Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
FV impact
-40% downside to current share price
Trigger
12-24 months
Deep Industrial Recession
· Medium
Prolonged global manufacturing and metals recession drives base volumes down, completely offsetting the downside protection of take-or-pay minimums.
FV impact
Drives valuation to $208.99 bear case
Trigger
18 months
Green Capex Value Trap
· Medium
Accelerated clean energy investments require structurally higher capex without commensurate return on invested capital, impairing FCFF generation.
FV impact
-15% structurally to base case valuation
Trigger
24-36 months
निगरानी हेतु शीघ्र चेतावनी संकेत
मेट्रिक
वर्तमान
ट्रिगर सीमा
Capex to D&A ratio sustains aggressively above 1.5x without top-line revenue acceleration.
Monitor
Deterioration versus the report thesis
Measurable deterioration in renewal rates or pricing power for long-term take-or-pay contracts.
Monitor
Deterioration versus the report thesis
Global manufacturing PMI readings remaining decisively below 45 for three consecutive quarters.
Monitor
Deterioration versus the report thesis
Gross margin compression below 40%, signaling a loss of highly prized localized pricing power.
Monitor
Deterioration versus the report thesis
Significant downward revisions or delays in clean energy and hydrogen project backlogs.
Based on our latest analysis, LIN looks meaningfully overvalued. The current price is $493 versus a composite fair-value midpoint of $277 (range $209–$356), which implies roughly 43.9% downside to the midpoint.
Our composite fair-value range for LIN is $209–$356, with a midpoint of $277. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for Linde plc's archetype.
Our current rating for LIN is Sell with a confidence score of 87/100. LIN is rated Sell at $493.16 versus the reconciled fair value midpoint of $276.69, implying -43.89% upside/downside. Confidence is separately disclosed at 87/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for Linde plc are: Cyclical Multiple Reversion; Deep Industrial Recession; Green Capex Value Trap. The single biggest risk is Cyclical Multiple Reversion: Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
Our current rating for LIN is Sell, issued with a confidence score of 87/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($209–$356) versus the current price of $493.
Linde plc is classified as a cyclical stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for LIN.